The purpose of this project is to assist the Cancer Therapy Evaluation Program (CTEP), NCI in fulfilling itsresponsibilities in meeting the regulations set forth by the Food and Drug Administration (FDA) and the Department ofHealth and Human Services (DHHS) as an Independent New Drug (IND) sponsor and funding agency by monitoringNCI sponsored clinical trials.